IPL 2020: Chennai Super Kings bowler, staffers test COVID-19 positive

Apart from the Chennai Super Kings right-arm medium-fast bowler, at least 10 members of CSK's social media team and support staff have also tested COVID-19 positive.

Moneycontrol News

August 29, 2020 / 03:19 PM IST

A Chennai Super Kings bowler and at least 10 other members of the Indian Premier League (IPL) team have tested positive for the novel coronavirus. The team is currently in Dubai, where IPL 2020 will be held.

They were supposed to start their pre-season training camp from August 28, but the development has forced the CSK team to extend the quarantine period till September 1.

Apart from the Indian bowler, the others who have contracted COVID-19 were part of CSK’s social media team and support staff, reported India Today.

All the members of the IPL team who have tested coronavirus positive are stable now and will be kept in isolation for two weeks. CSK is following all safety protocols announced by the Board of Control for Cricket in India (BCCI).

The players and the support staff will not be allowed to enter the 'bio-secure' environment until their COVID-19 test results come negative. They will also have to undergo mandatory cardiac screening.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show